S.124: Preserve Access to Affordable Generics Act

About This Bill

Bill Version

Bill Summary

Preserve Access to Affordable Generics Act This bill amends the Federal Trade Commission Act to authorize the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug. Such an agreement, with specified exceptions, is presumed to have anticompetitive effects and is a violation of this bill if the filer of the abbreviated new...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 5 statements associated with S.124.

Bill Actions

Date Description
Jan. 12, 2017
Read twice and referred to the Committee on the Judiciary.
Jan. 12, 2017

Introduced in the Senate by Amy Klobuchar (D-Minn.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page